News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) Posts Loss, Cuts 2013 Sales Forecast


10/31/2013 7:17:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Valeant Pharmaceuticals International Inc posted a quarterly net loss that it attributed in part to restructuring and impairment charges, and Canada’s biggest publicly traded drugmaker cut its full-year revenue outlook. Valeant’s U.S.-listed shares fell nearly 4 per cent in trading before the bell on Thursday.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES